Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis

被引:23
|
作者
Monz, Brigitta U. [1 ]
Sachs, Paul [2 ,3 ]
McDonald, Jeffrey [4 ]
Crawford, Bruce [5 ]
Nivens, Michael C. [6 ]
Tetzlaff, Kay [6 ,7 ]
机构
[1] Boehringer Ingelhelm GmbH, D-55216 Ingelheim, Germany
[2] Stamford Hosp, Stamford, CT 06902 USA
[3] Columbia Univ, Coll Phys & Surg, New York, NY 10027 USA
[4] Mapi Values, Boston, MA 02114 USA
[5] Mapi Values, Tokyo 1530064, Japan
[6] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
[7] Univ Tubingen, Dept Sports Med, Med Clin, D-72076 Tubingen, Germany
关键词
Cough and sputum assessment questionnaire; COPD; Chronic bronchitis; Exacerbations; Responsiveness; OBSTRUCTIVE PULMONARY-DISEASE; SMOKING-CESSATION; TIME-COURSE; BREATHLESSNESS; VALIDATION; MANAGEMENT; RECOVERY; SYMPTOMS;
D O I
10.1016/j.rmed.2009.10.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: To assess the responsiveness of the Cough and Sputum Assessment Questionnaire (CASA-Q) in COPD and chronic bronchitis patients recovering from an acute exacerbation. The 20-item questionnaire with a 7-day recall assesses the frequency and severity of cough and sputum and their impact on everyday life in clinical (trial) settings. The four domains (cough/sputum symptom and impact) use scales from 0 to 100, with lower scores indicating higher symptom/impact levels. Methods: Outpatients were enrolled within 48 h of symptom onset of their exacerbation. Treatment was initiated at the discretion of the investigator, and patients observed for 6 weeks. During study visits, 59 eligible patients completed the CASA-Q at enrolment, week 1, 2 and 6. Responsiveness was assessed by calculating standardized effect sizes. Results: Of the 19 male and 40 female patients with a mean (standard deviation, SD) age of 61.1 (10.5) years, all were classified by their physician to have improved or recovered after six weeks. The mean (SD) CASA-Qsores for the cough symptom, cough impact, sputum symptom and sputum impact domains increased from 32.6 (21.0), 40.7 (22.4), 37.4 (20.1), 47.1 (24.2) at enrolment to 54.0 (19.8), 63.7 (21.3), 55.1 (19.0), 65.5 (20.5) at week 6, respectively. Standardized effect sizes for patients improved or recovered from their exacerbation at week 6 were above 1.0 for the cough domains and at least 0.77 for the sputum domains. Conclusions: The CASA-Q was responsive to symptom changes in patients recovering from an exacerbation. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 50 条
  • [21] Identification and assessment of COPD exacerbations
    Oliveira, A. S.
    Munha, J.
    Bugalho, A.
    Guimaraes, M.
    Reis, G.
    Marques, A.
    PULMONOLOGY, 2018, 24 (01): : 42 - 47
  • [22] The validity and precision of the leicester cough questionnaire in COPD patients with chronic cough
    Farida F Berkhof
    Lisenka N Boom
    Nynke E ten Hertog
    Steven M Uil
    Huib AM Kerstjens
    Jan WK van den Berg
    Health and Quality of Life Outcomes, 10
  • [23] Efficacy and safety of moxifloxacin in acute exacerbations of chronic bronchitis: a prospective, multicenter, observational study (AVANTI)
    Chuchalin, Alexander
    Zakharova, Maryna
    Dokic, Dejan
    Tokic, Mahir
    Marschall, Hans-Peter
    Petri, Thomas
    BMC PULMONARY MEDICINE, 2013, 13
  • [24] Systemic interleukin-26 relates to the risk of exacerbations in smokers with COPD and chronic bronchitis
    Lundgren, Rickard
    Andelid, Kristina
    Ezerskyte, Monika
    Pournaras, Nikolaos
    Brundin, Bettina
    Che, Karlhans Fru
    Linden, Anders
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [25] Pancreatic Stone Protein Predicts Positive Sputum Bacteriology in Exacerbations of COPD
    Scherr, Andreas
    Graf, Rolf
    Bain, Martha
    Christ-Crain, Mirjam
    Mueller, Beat
    Tamm, Michael
    Stolz, Daiana
    CHEST, 2013, 143 (02) : 379 - 387
  • [26] Is The CAT Questionnaire Sensitive To Changes In Health Status In Patients With Severe COPD Exacerbations?
    Agusti, Alvar
    Soler, Juan J.
    Molina, Jesus
    Munoz, Maria Jose
    Garcia-Losa, Manuel
    Roset, Montserrat
    Jones, Paul W.
    Badia, Xavier
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2012, 9 (05) : 492 - 498
  • [27] Cough and sputum production as risk factors for poor outcomes in patients with COPD
    Miravitlles, Marc
    RESPIRATORY MEDICINE, 2011, 105 (08) : 1118 - 1128
  • [28] Changes in the induced sputum proteome during COPD exacerbations
    Haaland, Ingvild
    Aardal, Marit E.
    Berven, Frode S.
    Vaudel, Marc
    Nielsen, Rune
    Aanerud, Marianne
    Hardie, Jon A.
    Bakke, Per S.
    Eagan, Tomas M.
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [29] Subjects with COPD and productive cough have an increased risk for exacerbations and death
    Lindberg, Anne
    Sawalha, Sami
    Hedman, Linnea
    Larsson, Lars-Gunnar
    Lundback, Bo
    Ronmark, Eva
    RESPIRATORY MEDICINE, 2015, 109 (01) : 88 - 95
  • [30] Management of chronic bronchitis and acute exacerbations of chronic bronchitis
    Balter, M
    Grossman, RF
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1997, 9 (02) : 83 - 93